×
About 10,030 results

ALLMedicine™ Parkinson Disease Center

Research & Reviews  3,659 results

Imaging Biomarkers in Parkinson s Disease
https://clinicaltrials.gov/ct2/show/NCT01496599

May 20th, 2022 - Objectives: The purpose of this protocol is to evaluate possible imaging biomarkers for diagnosis and assessment of disease progression in Parkinson disease (PD) through multi-modal neuroimaging studies. The study will have two parts: Part 1: Comp...

Genetic Studies of Lysosomal Storage Disorders
https://clinicaltrials.gov/ct2/show/NCT00001215

May 20th, 2022 - There is a vast spectrum of clinical manifestations encountered in individuals with lysosomal storage diseases. Lysosomal storage disorders occur when an enzyme necessary for breaking down intracellular fats, proteins, recycled products and organe...

DBS and Respiration
https://clinicaltrials.gov/ct2/show/NCT04058457

May 19th, 2022 - A continuous cohort of Parkinson disease patients planned to undergo STN-DBS will be approached to participate in this study (i.e. every patient will be offered participation in the study). Over the same time period other DBS patients (GPi and VIM...

Quantitative Assessment of Training Effects Using EKSOGT Exoskeleton in Quantitative Assessment of Training Effects Using EKSOGT Exoskeleton in Parkinson Disease Patients
https://clinicaltrials.gov/ct2/show/NCT04778852

May 18th, 2022 - Full Title: QUANTITATIVE ASSESSMENT OF TRAINING EFFECTS USING A WEARABLE EXOSKELETON IN PARKINSON DISEASE PATIENTS RESEARCH PLAN Specific Aims The ability to walk independently is a primary goal when rehabilitating an individual with Parkinson Dis...

The Effect of Rotigotine on Cognitive Function, Daytime Sleepiness, and Sleep Problems ...
https://doi.org/10.1097/WNF.0000000000000501
Clinical Neuropharmacology; Suzuki K, Funakoshi K et. al.

May 18th, 2022 - We hypothesized that rotigotine may have a positive effect on cognitive function in patients with Parkinson disease (PD) by improving daytime motor function and sleep status. Fifteen PD patients with sleep disturbances, defined as a PD Sleep Scale...

see more →

Guidelines  1 results

Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline From ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046970
Physical Therapy; Osborne JA, Botkin R et. al.

Dec 29th, 2021 - A clinical practice guideline on Parkinson disease was developed by an American Physical Therapy Association volunteer guideline development group that consisted of physical therapists and a neurologist. The guideline was based on systematic revie...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  137 results

Imaging Biomarkers in Parkinson s Disease
https://clinicaltrials.gov/ct2/show/NCT01496599

May 20th, 2022 - Objectives: The purpose of this protocol is to evaluate possible imaging biomarkers for diagnosis and assessment of disease progression in Parkinson disease (PD) through multi-modal neuroimaging studies. The study will have two parts: Part 1: Comp...

Genetic Studies of Lysosomal Storage Disorders
https://clinicaltrials.gov/ct2/show/NCT00001215

May 20th, 2022 - There is a vast spectrum of clinical manifestations encountered in individuals with lysosomal storage diseases. Lysosomal storage disorders occur when an enzyme necessary for breaking down intracellular fats, proteins, recycled products and organe...

DBS and Respiration
https://clinicaltrials.gov/ct2/show/NCT04058457

May 19th, 2022 - A continuous cohort of Parkinson disease patients planned to undergo STN-DBS will be approached to participate in this study (i.e. every patient will be offered participation in the study). Over the same time period other DBS patients (GPi and VIM...

Quantitative Assessment of Training Effects Using EKSOGT Exoskeleton in Quantitative Assessment of Training Effects Using EKSOGT Exoskeleton in Parkinson Disease Patients
https://clinicaltrials.gov/ct2/show/NCT04778852

May 18th, 2022 - Full Title: QUANTITATIVE ASSESSMENT OF TRAINING EFFECTS USING A WEARABLE EXOSKELETON IN PARKINSON DISEASE PATIENTS RESEARCH PLAN Specific Aims The ability to walk independently is a primary goal when rehabilitating an individual with Parkinson Dis...

Role of Nasal Dysbiosis in Parkinson Disease
https://clinicaltrials.gov/ct2/show/NCT04249245

Apr 28th, 2022 - Olfactory dysfunction is frequent in Parkinson Disease (PD) and may be present years before the motor symptoms appear. The early olfactory dysfunction could result from environmental factors acting through the nasal cavity such as microbial commun...

see more →

News  205 results

Lithium Linked to Dementia Prevention
https://www.medpagetoday.com/psychiatry/dementia/97725

Mar 17th, 2022 - Treatment with lithium may be protective against dementia and its subtypes, a retrospective cohort study indicated. Among patients receiving mental health care, those exposed to lithium at standard clinical dosages had a 44% lower risk of receivin...

Neurology Case Challenge: Visual and Auditory Hallucinations in a Patient With Parkinson Disease
https://www.medscape.com/viewarticle/736108

Jan 21st, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Survey identifies clinicians’ unease with genetic testing
https://www.mdedge.com/neurology/article/246396/parkinsons-disease/survey-identifies-clinicians-unease-genetic-testing
Richard Mark Kirkner

Sep 21st, 2021 - Before getting to work on developing guidelines for genetic testing in Parkinson’s disease, a task force of the Movement Disorders Society surveyed members worldwide to identify concerns they have about using genetic testing in practice. In result.

Sublingual Film Well-Tolerated for Parkinson 'Off' Episodes
https://www.medscape.com/viewarticle/959036

Sep 19th, 2021 - A majority of patients with Parkinson disease (PD) experiencing "off" episodes  successfully tolerated titration to an effective and tolerable dose of sublingual apomorphine film (SL-apo; Kynmobi, Sunovion Pharmaceuticals) without the use of antie...

Antioxidant Therapy Tested in Early Parkinson’s
https://www.medpagetoday.com/neurology/parkinsonsdisease/94508

Sep 14th, 2021 - Treatment with the urate precursor inosine did not result in a significant difference in the rate of clinical disease progression in early Parkinson's disease, the phase III SURE-PD3 trial showed. Clinical progression rates, measured by the Moveme...

see more →

Patient Education  3 results see all →